0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.24%
Negative revenue growth while 0376.HK stands at 204.46%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-24.76%
Negative gross profit growth while 0376.HK is at 204.46%. Joel Greenblatt would examine cost competitiveness or demand decline.
46.87%
EBIT growth of 46.87% while 0376.HK is zero. Bruce Berkowitz would see if small gains can be scaled further.
46.87%
Operating income growth under 50% of 0376.HK's 1055.81%. Michael Burry would be concerned about deeper cost or sales issues.
-112.51%
Negative net income growth while 0376.HK stands at 978.61%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-112.61%
Negative EPS growth while 0376.HK is at 811.11%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-114.85%
Negative diluted EPS growth while 0376.HK is at 811.11%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.05%
Share reduction while 0376.HK is at 23.12%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-14.84%
Reduced diluted shares while 0376.HK is at 23.13%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-146.12%
Negative OCF growth while 0376.HK is at 1083.10%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-96.66%
Negative FCF growth while 0376.HK is at 1465.89%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-33.83%
Negative 10Y revenue/share CAGR while 0376.HK stands at 1337.07%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-41.53%
Negative 5Y CAGR while 0376.HK stands at 1624.58%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-33.91%
Negative 3Y CAGR while 0376.HK stands at 2504.45%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2026.74%
Negative 10Y OCF/share CAGR while 0376.HK stands at 276.45%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-330.94%
Negative 5Y OCF/share CAGR while 0376.HK is at 324.56%. Joel Greenblatt would question the firm’s operational model or cost structure.
-107.08%
Negative 3Y OCF/share CAGR while 0376.HK stands at 268.12%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-102.98%
Negative 10Y net income/share CAGR while 0376.HK is at 112.24%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-105.81%
Negative 5Y net income/share CAGR while 0376.HK is 125.41%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-104.20%
Negative 3Y CAGR while 0376.HK is 127.77%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
631.56%
Equity/share CAGR of 631.56% while 0376.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
14.54%
Below 50% of 0376.HK's 709.76%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.89%
Below 50% of 0376.HK's 54.55%. Michael Burry suspects a serious short-term disadvantage in building book value.
-92.85%
Cut dividends over 10 years while 0376.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-19.58%
Negative 5Y dividend/share CAGR while 0376.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-39.20%
Negative near-term dividend growth while 0376.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-22.12%
Firm’s AR is declining while 0376.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
23.92%
Inventory growth of 23.92% while 0376.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-8.19%
Negative asset growth while 0376.HK invests at 6.01%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.51%
Positive BV/share change while 0376.HK is negative. John Neff sees a clear edge over a competitor losing equity.
38.08%
Debt growth far above 0376.HK's 75.38%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-67.10%
Our R&D shrinks while 0376.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-20.20%
We cut SG&A while 0376.HK invests at 54.85%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.